Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Glenwood GmbH, Pharmazeutische Erzeugnisse, Arabellastrasse 17, 81925 Munich, Germany
Plendil 2.5 mg prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release tablet. Plendil 2.5 mg: The tablet is yellow, circular, biconvex, engraved A/FL on one side and 2.5 on the other side, with a diameter of 8.5 mm. |
Each tablet contains 2.5 mg felodipine.
Excipients with known effect: Each tablet contains 28 mg lactose and 2.5 mg macrogolglycerol hydroxystearate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Felodipine |
Felodipine is a vascular selective calcium antagonist, which lowers arterial blood pressure by decreasing systemic vascular resistance. Felodipine is effective in all grades of hypertension. |
| List of Excipients |
|---|
|
Tablet core: Hydroxypropylcellulose Coating: Carnauba wax |
High-density polyethylene bottle with a standard cap of polypropylene.
PVC/PVDC/Aluminium blister.
Blister pack:
20 tablets (blister pack)
28 tablets (calendar blister pack)
30 tablets (blister pack)
50 tablets (unit-dose pack)
98 tablets (calendar blister pack)
100 tablets (blister pack)
Plastic bottle:
30 tablets (bottle)
100 tablets (bottle)
500 tablets (bottle for dose dispensing)
Not all pack sizes may be marketed.
Glenwood GmbH, Pharmazeutische Erzeugnisse, Arabellastrasse 17, 81925 Munich, Germany
PA2256/005/001
Date of first authorisation: 19 May 1997
Date of last renewal: 18 May 2007
| Drug | Countries | |
|---|---|---|
| PLENDIL | Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
